68Ga-PSMA-11 PET/CT in assessment of prostate cancer patients - comparison with 18F-Choline PET/CT with regard topatient's management and therapy monitoring

被引：0
|
作者：
Beheshti, M. [1 ,2 ]
Paymani, Z. [1 ,3 ]
Geinitz, H. [4 ]
Moinfar, F. [5 ]
Loidl, W. [6 ]
Langsteger, W. [1 ]
机构：
[1] St Vincents Hosp, IPET CT Ctr Linz, Linz, Austria
[2] Paracelsus Med Univ, Nucl Med, Salzburg, Austria
[3] Shariati Hosp, Res Ctr Nucl Med, Tehran, Iran
[4] St Vincents Hosp, Dept Radiat Oncol, Linz, Austria
[5] St Vincents Hosp, Dept Clin Pathol, Linz, Austria
[6] St Vincents Hosp, Dept Urol, Linz, Austria
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2018年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0587
引用
收藏
页码：S532 / S532
页数：1
相关论文
共 50 条
  • [1] Comparison of 68Ga-PSMA-11 PET/CT and 18F-Fluciclovine PET/CT in recurrent Prostate Cancer
    Ceci, F.
    Polverari, G.
    Gartmann, J.
    Fendler, W.
    Eiber, M.
    Herrmann, K.
    Czernin, J.
    Calais, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S150 - S150
  • [2] Diagnostic Performance of 68Ga-PSMA PET/CT to Detect Significant Prostate Cancer and Comparison with 18F-Choline PET/CT
    Hoffmann, Manuela
    Wieler, Helmut
    Maus, Stephan
    Jakobs, Frank
    Schreckenberger, Mathias
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [3] 68Ga-PSMA PET/CT in Staging and Restaging of prostate Cancer Patients: Comparative Study with 18F-Choline PET/CT
    Langsteger, W.
    Imamovic, L.
    Geinitz, H.
    Schiller, C.
    Moinfar, F.
    Rezaee, A.
    Pallwein-Prettner, L.
    Loidl, W.
    Beheshti, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S166 - S166
  • [4] 68Ga-PSMA-11 PET/CT in patients with occult biochemical recurrence of prostate carcinoma and negative 18F-Choline PET/CT. Preliminary assessment of its clinical use
    Plaza Lopez, P. J.
    Puertas, E.
    Aguilo, J. J.
    Suarez-Pinera, M.
    Domenech, B.
    Mestre-Fusco, A.
    Casals, J.
    Chicharo de Fleitas, J. R.
    ACTAS UROLOGICAS ESPANOLAS, 2021, 45 (05): : 353 - 358
  • [5] 68Ga-PSMA-PET/CT after a non-contributively 18F-Choline PET/CT in patients in biochemical relapse of prostate cancer
    Skanjeti, Andrea
    Hallouard, Francois
    Dhomps, Anthony
    Darcissac, Caroline
    Morelec, Isabelle
    Got, Philippe
    Deville, Agathe
    Tordo, Jeremie
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [6] 68Ga-PSMA-11 PET/CT and ADT Monitoring
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (05) : 22N - 22N
  • [7] Comparison of 18F-NaF PET and 68Ga-PSMA-11 PET/CT in the evaluation of bone metastasis in metastatic prostate cancer patients
    Svirydenka, Hanna
    Uprimny, Christian
    Maffey-Steffan, Johanna
    Nilica, Bernhard
    Decristoforo, Clemens
    Horninger, Wolfgang
    Virgolini, Irene
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [8] 18F-Choline Versus 68Ga-PSMA-11 PET/CT Imaging Comparison in Incidental Clear Cell Renal Cell Carcinoma
    Urso, Luca
    Rocca, Giovanni Christian
    Uccelli, Licia
    Ippolito, Carmelo
    Bartolomei, Mirco
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (04) : E178 - E180
  • [9] Impact of 68Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence
    Calais, Jeremie
    Fendler, Wolfgang P.
    Eiber, Matthias
    Gartmann, Jeannine
    Chu, Fang-I
    Nickols, Nicholas G.
    Reiter, Robert E.
    Rettig, Matthew B.
    Marks, Leonard S.
    Ahlering, Thomas E.
    Huynh, Linda M.
    Slavik, Roger
    Gupta, Pawan
    Quon, Andrew
    Allen-Auerbach, Martin S.
    Czernin, Johannes
    Herrmann, Ken
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (03) : 434 - 441
  • [10] The additional value of 18F-FDG PET/CT compared to 68Ga-PSMA-11 PET/CT in initial diagnosed prostate cancer patients
    Wang, Yining
    Liu, Jianjun
    Chen, Ruohua
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
12345